Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 2
1985 2
1986 1
1987 12
1988 7
1989 8
1990 4
1991 1
1992 4
1993 2
1995 1
1996 4
1997 3
1998 6
1999 5
2000 4
2001 7
2002 7
2003 4
2004 3
2005 9
2006 8
2007 13
2008 10
2009 8
2010 16
2011 13
2012 19
2013 12
2014 10
2015 11
2016 13
2017 15
2018 18
2019 19
2020 22
2021 19
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

302 results
Results by year
Filters applied: . Clear all
Page 1
Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, Conte M, Rosato C, Ciniglio Appiani M, de Vincentiis M. De Virgilio A, et al. Among authors: fabbrini g. Autoimmun Rev. 2016 Oct;15(10):1005-11. doi: 10.1016/j.autrev.2016.07.022. Epub 2016 Aug 4. Autoimmun Rev. 2016. PMID: 27497913 Review.
Facial bradykinesia.
Bologna M, Fabbrini G, Marsili L, Defazio G, Thompson PD, Berardelli A. Bologna M, et al. Among authors: fabbrini g. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):681-5. doi: 10.1136/jnnp-2012-303993. Epub 2012 Dec 12. J Neurol Neurosurg Psychiatry. 2013. PMID: 23236012 Review.
Levodopa-induced dyskinesias.
Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Fabbrini G, et al. Mov Disord. 2007 Jul 30;22(10):1379-1389. doi: 10.1002/mds.21475. Mov Disord. 2007. PMID: 17427940 Review.
European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
Deuschl G, Antonini A, Costa J, Śmiłowska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E. Deuschl G, et al. Among authors: fabbrini g. Mov Disord. 2022 Jul;37(7):1360-1374. doi: 10.1002/mds.29066. Epub 2022 Jul 6. Mov Disord. 2022. PMID: 35791767 Review.
Investigational drugs.
Colosimo C, Fabbrini G. Colosimo C, et al. Among authors: fabbrini g. Handb Clin Neurol. 2007;84:137-50. doi: 10.1016/S0072-9752(07)84037-1. Handb Clin Neurol. 2007. PMID: 18808946 No abstract available.
Corticobasal syndrome: neuroimaging and neurophysiological advances.
Di Stasio F, Suppa A, Marsili L, Upadhyay N, Asci F, Bologna M, Colosimo C, Fabbrini G, Pantano P, Berardelli A. Di Stasio F, et al. Among authors: fabbrini g. Eur J Neurol. 2019 May;26(5):701-e52. doi: 10.1111/ene.13928. Epub 2019 Mar 15. Eur J Neurol. 2019. PMID: 30720235 Review.
Salivary caffeine in Parkinson's disease.
Leodori G, De Bartolo MI, Belvisi D, Ciogli A, Fabbrini A, Costanzo M, Manetto S, Conte A, Villani C, Fabbrini G, Berardelli A. Leodori G, et al. Among authors: fabbrini g. Sci Rep. 2021 May 10;11(1):9823. doi: 10.1038/s41598-021-89168-6. Sci Rep. 2021. PMID: 33972579 Free PMC article.
302 results